Voyager Therapeut (VYGR) Stock Price, Quote & News

Company Profile

Voyager Therapeutics, Inc., a biotechnology company, focuses on the human genetics for the cure of neurological diseases. The company's lead product candidate is VY7523, an anti-tau antibody program for the treatment of alzheimer's disease (AD). Its product pipeline includes VY1706, a tau silencing gene therapy in preclinical trial for the treatment of alzheimer's disease; SOD1 silencing gene therapy program for treating amyotrophic lateral sclerosis in preclinical trial; and vectorized anti-amy...

Industry: Biotechnology

Sector: Healthcare

Phone: 857 259 5340

Website: www.voyagertherapeutics.com

Address:

75 Hayden Avenue, Lexington, United States

ASTANA Oct. 26 at 8:42 PM

$RNA $VYGR

0 · Reply

NPLBMF Oct. 24 at 11:39 AM

Why is this happening? Stocktwits spamming $RXRX board. Team, please do this for $VYGR next so I can get my money back. THANO UPI FOR UOUR ATNTION TO THIS MATER

0 · Reply

tumanako Oct. 22 at 1:33 AM

$VYGR Buying opportunities

0 · Reply

NYBomba Oct. 8 at 10:12 PM

$VYGR - Golden Cross happening tomorrow with MACD way above the line and RSI just hitting 70 (and the MM/Specialist will prepare accordingly) ... VYGR MM/Specialist are donuts with their wide spreads so watch out ... should be interesting going into the weekend... GLTA

0 · Reply

Chrissytina Oct. 8 at 7:39 PM

$VYGR 1.34 million in volume but it’s not here and trust me👇🏻😁👍🏻

0 · Reply

pickens1 Oct. 8 at 6:48 PM

$VYGR Nathan Jorgensen, CFO of Voyager Therapeutics, sold 7,666 shares at an average price of $4.78 Oct 3 He Shi$ a Brick today .

1 · Reply

WestEgg Oct. 8 at 5:16 PM

$VYGR possible undisclosed pipeline data will be disclosed. This could easily be $40-$60 with positive news.

0 · Reply

Shawnnielsen Oct. 8 at 4:26 PM

$VYGR easy dubs boys

0 · Reply

juicy123 Oct. 8 at 2:56 PM

$VYGR anyone know why I would be up over 50% on this in the last 3 months? I don’t know, but I’ll take it

2 · Reply

BigDaddyPumper Oct. 6 at 8:34 PM

$VYGR BDP says see you at 8$

0 · Reply

Voyager Therapeutics, Inc. (VYGR) Presents At Citi's Biopharma Back To School Conference Transcript

Aug 26, 2025, 7:00 AM EDT - 2 months ago

Voyager to Present at Upcoming Investor Conferences

Aug 6, 2025, 4:01 PM EDT - 2 months ago

Voyager Reports Second Quarter 2025 Financial and Operating Results

Jul 16, 2025, 7:00 AM EDT - 3 months ago

Voyager Adds Fourth Wholly-Owned Alzheimer's Disease Program to Pipeline, Complementing Existing Tau and Amyloid Assets with New APOE Approach

Jun 10, 2025, 7:00 AM EDT - 4 months ago

Voyager to Present at H.C. Wainwright 6th Annual Neuro Perspectives Hybrid Conference

May 15, 2025, 7:00 AM EDT - 5 months ago

Voyager Demonstrates ALPL Receptor-Mediated Blood-Brain Barrier Transport of Novel AAV Capsids in Molecular Therapy Publication

May 6, 2025, 4:01 PM EDT - 6 months ago

Voyager Reports First Quarter 2025 Financial and Operating Results

Apr 28, 2025, 4:30 PM EDT - 6 months ago

Voyager Next-Generation CNS Capsids Featured at ASGCT 28th Annual Meeting

Mar 31, 2025, 7:00 AM EDT - 7 months ago

Voyager Presents Robust Preclinical Data from Tau Targeting Gene Therapy and Antibody Programs at AD/PD™ 2025

Mar 11, 2025, 7:35 PM EDT - 8 months ago

Voyager Therapeutics, Inc. (VYGR) Q4 2024 Earnings Call Transcript

Mar 11, 2025, 4:01 PM EDT - 8 months ago

Voyager Reports Fourth Quarter and Full Year 2024 Financial and Operating Results

Mar 4, 2025, 7:00 AM EST - 8 months ago

Voyager Therapeutics Announces Fourth Quarter 2024 Conference Call and Webcast

Mar 3, 2025, 7:00 AM EST - 8 months ago

Voyager Reports Positive Topline Data for Single Ascending Dose (SAD) Trial of Anti-Tau Antibody VY7523 and Initiates Multiple Ascending Dose (MAD) Trial in Alzheimer's Disease

Mar 2, 2025, 11:00 AM EST - 8 months ago

The Schall Law Firm Invites Shareholders With Losses In Voyager Therapeutics, Inc. To Join A Securities Fraud Investigation

Feb 25, 2025, 7:00 AM EST - 8 months ago

Voyager Therapeutics to Present at Multiple Upcoming Investor Conferences

Feb 21, 2025, 10:51 PM EST - 8 months ago

VYGR Investors Have Opportunity to Join Voyager Therapeutics, Inc. Fraud Investigation with the Schall Law Firm

Feb 11, 2025, 7:00 AM EST - 9 months ago

Voyager Provides Update on SOD1 ALS Gene Therapy Program

Jan 30, 2025, 5:06 PM EST - 9 months ago

Voyager: Crossing The Blood-Brain Barrier, Competitors, And Investment Relevance

Nov 12, 2024, 11:07 PM EST - 1 year ago

Voyager Therapeutics, Inc. (VYGR) Q3 2024 Earnings Call Transcript

Nov 12, 2024, 4:01 PM EST - 1 year ago

Voyager Reports Third Quarter 2024 Financial and Operating Results

Nov 5, 2024, 7:00 AM EST - 1 year ago

Voyager Therapeutics Announces Third Quarter 2024 Conference Call and Webcast

Aug 29, 2024, 4:01 PM EDT - 1 year ago

Voyager Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Aug 26, 2024, 3:24 PM EDT - 1 year ago

Voyager: Anti-Tau Antibody Differentiation For AD Treatment Could Boost Prospects

Aug 8, 2024, 5:43 AM EDT - 1 year ago

Voyager Therapeutics, Inc. (VYGR) Q2 2024 Earnings Call Transcript

Aug 7, 2024, 7:00 AM EDT - 1 year ago

Voyager Therapeutics to Present at Canaccord Genuity 44th Annual Growth Conference & Private Company Showcase

Aug 6, 2024, 4:01 PM EDT - 1 year ago

Voyager Therapeutics Reports Second Quarter 2024 Financial and Operating Results

Jun 13, 2024, 4:01 PM EDT - 1 year ago

Voyager Therapeutics to Present at Multiple Virtual Investor Conferences

Jun 13, 2024, 7:00 AM EDT - 1 year ago

Voyager Therapeutics Announces Appointment of Nathan Jorgensen as Chief Financial Officer

Jun 7, 2024, 6:26 PM EDT - 1 year ago

The 'Undercovered' Dozen From June 1-6

ALNY CLOV CRSP ENVX GAM HAL LPA

Jun 5, 2024, 11:52 AM EDT - 1 year ago

Voyager: Alzheimer's Clinical Trial Start (VY-TAU01) Strengthens Investment Thesis

Jun 2, 2024, 10:18 AM EDT - 1 year ago

3 Biotech Names Under $10 I Own

AUPH FOLD

May 16, 2024, 7:00 AM EDT - 1 year ago

Voyager Therapeutics Announces First Participants Dosed in Single Ascending Dose Trial of VY-TAU01 for the Treatment of Alzheimer's Disease

May 14, 2024, 4:43 AM EDT - 1 year ago

Voyager Therapeutics, Inc. (VYGR) Q1 2024 Earnings Call Transcript

May 13, 2024, 4:01 PM EDT - 1 year ago

Voyager Therapeutics Reports First Quarter 2024 Financial and Operating Results

May 8, 2024, 6:00 AM EDT - 1 year ago

Voyager Therapeutics Presents Data for Second-Generation, TRACER™-Generated Capsids and CNS Gene Therapy Programs Advancing Toward Clinical Trials at the ASGCT 27th Annual Meeting

ASTANA Oct. 26 at 8:42 PM

$RNA $VYGR

0 · Reply

NPLBMF Oct. 24 at 11:39 AM

Why is this happening? Stocktwits spamming $RXRX board. Team, please do this for $VYGR next so I can get my money back. THANO UPI FOR UOUR ATNTION TO THIS MATER

0 · Reply

tumanako Oct. 22 at 1:33 AM

$VYGR Buying opportunities

0 · Reply

NYBomba Oct. 8 at 10:12 PM

0 · Reply

Chrissytina Oct. 8 at 7:39 PM

$VYGR 1.34 million in volume but it’s not here and trust me👇🏻😁👍🏻

0 · Reply

pickens1 Oct. 8 at 6:48 PM

$VYGR Nathan Jorgensen, CFO of Voyager Therapeutics, sold 7,666 shares at an average price of $4.78 Oct 3 He Shi$ a Brick today .

1 · Reply

WestEgg Oct. 8 at 5:16 PM

$VYGR possible undisclosed pipeline data will be disclosed. This could easily be $40-$60 with positive news.

0 · Reply

Shawnnielsen Oct. 8 at 4:26 PM

$VYGR easy dubs boys

0 · Reply

juicy123 Oct. 8 at 2:56 PM

$VYGR anyone know why I would be up over 50% on this in the last 3 months? I don’t know, but I’ll take it

2 · Reply

BigDaddyPumper Oct. 6 at 8:34 PM

$VYGR BDP says see you at 8$

0 · Reply

biotech Oct. 3 at 5:39 PM

$SGMO $VYGR

0 · Reply

biotech Oct. 3 at 8:44 AM

$SGMO $VYGR

0 · Reply

SilentSniper Oct. 2 at 5:45 PM

$SGMO $VYGR hell yes!..linking your old post..

1 · Reply

biotech Oct. 2 at 5:12 PM

$SGMO killing competition if you let them $VYGR losing bigtime VS $SGMO capsids ... so... $VYGR capitulated on AAV Capsids? and introducing: "Voyager-NeuroShuttle Non-Viral Platform" 🤓 "Proof of concept murine data" "Preclinical studies ongoing to identify potential safety profile of ALPL-VYGR-NeuroShuttle" good luck , LOL !

2 · Reply

DARKP00L Oct. 1 at 5:34 PM

$VYGR this stock is attracting a lot of interest. Be prepared for possible changes!

0 · Reply

Shawnnielsen Sep. 26 at 6:07 PM

$VYGR let’s goooo

0 · Reply

jm4 Sep. 26 at 5:57 PM

$VYGR

0 · Reply

Orlandotrader Sep. 25 at 8:26 PM

$VYGR Gonna need to start so Real Trials to move this. Better get going in 2026.

0 · Reply

pickens1 Sep. 18 at 7:34 PM

$VYGR She was sitting on $2.96 pickens1 Jun 26, 2025 2:51 PM $VYGR She is on sale... Bullish

0 · Reply

Orlandotrader Sep. 18 at 7:00 PM

$VYGR We Grind Higher!!!

0 · Reply

DARKP00L Sep. 15 at 6:35 PM

$VYGR 14:01 on Sep. 15 2025 Voyager Therapeutics Alzheimer's Portfolio And ALPL NeuroShuttle Underscore Platform Momentum: Analyst #tradeideas

0 · Reply

DARKP00L Sep. 15 at 6:35 PM

$VYGR 14:00 on Sep. 15 2025 Voyager Therapeutics Alzheimer's Portfolio And ALPL NeuroShuttle Underscore Platform Momentum: Analyst #tradeideas

0 · Reply

Market Cap	257.93M
Revenue (ttm)	80.00M
Net Income (ttm)	-65.00M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-81.25%
Debt to Equity Ratio	0.00

Volume	483,800
Avg Vol	732,118
Day's Range	N/A - N/A
Shares Out	55.47M
Stochastic %K	28%
Beta	0.95
Analysts	Strong Sell
Price Target	$15.08